Nuclear factor kappa B

被引:287
作者
Barnes, PJ
机构
[1] Department of Thoracic Medicine, Imp. Sch. of Medicine National Heart, Lung Institute, London SW3 6LY, Dovehouse Street
关键词
D O I
10.1016/S1357-2725(96)00159-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear factor-kappa B (NF-kappa B) is a ubiquitous transcription factor that, by regulating the expression of multiple inflammatory and immune genes, plays a critical role in host defence and in chronic inflammatory diseases, It is a heterodimer, present in the cytoplasm in an inactive form complexed to an inhibitory protein, I kappa B, Many extracellular stimuli, including viruses, oxidants, inflammatory cytokines and immune stimuli, activate NF-kappa B, Once activated, it binds to recognition elements in the promoter regions of inflammatory and immune genes, such as proinflammatory cytokines, chemokines, inflammatory enzymes and adhesion molecules. Glucocorticoids inhibit activated NF-kappa B and this is likely to be important in the anti-inflammatory action of steroids, Novel inhibitors of NF-kappa B are now under development for treatment of inflammatory diseases such as asthma, rheumatoid arthritis and inflammatory bowel disease. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:867 / 870
页数:4
相关论文
共 15 条
  • [1] ADCOCK IM, 1995, AM J PHYSIOL, V37, pC331
  • [2] IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS
    AUPHAN, N
    DIDONATO, JA
    ROSETTE, C
    HELMBERG, A
    KARIN, M
    [J]. SCIENCE, 1995, 270 (5234) : 286 - 290
  • [3] BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
  • [4] Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases
    Barnes, PJ
    Larin, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) : 1066 - 1071
  • [5] Glucocorticoid-mediated repression of NF kappa B activity in endothelial cells does not involve induction of I kappa B alpha synthesis
    Brostjan, C
    Anrather, J
    Csizmadia, V
    Stroka, D
    Soares, M
    Bach, FH
    Winkler, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) : 19612 - 19616
  • [6] Klement JF, 1996, MOL CELL BIOL, V16, P2341
  • [7] NF-AT-AP-1 AND REL-BZIP - HYBRID VIGOR AND BINDING UNDER THE INFLUENCE
    NOLAN, GP
    [J]. CELL, 1994, 77 (06) : 795 - 798
  • [8] PHYSICAL ASSOCIATION AND FUNCTIONAL ANTAGONISM BETWEEN THE P65 SUBUNIT OF TRANSCRIPTION FACTOR NF-KAPPA-B AND THE GLUCOCORTICOID RECEPTOR
    RAY, A
    PREFONTAINE, KE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) : 752 - 756
  • [9] REACTIVE OXYGEN INTERMEDIATES AS APPARENTLY WIDELY USED MESSENGERS IN THE ACTIVATION OF THE NF-KAPPA-B TRANSCRIPTION FACTOR AND HIV-1
    SCHRECK, R
    RIEBER, P
    BAEUERLE, PA
    [J]. EMBO JOURNAL, 1991, 10 (08) : 2247 - 2258
  • [10] MULTIPLE NUCLEAR FACTORS INTERACT WITH THE IMMUNOGLOBULIN ENHANCER SEQUENCES
    SEN, R
    BALTIMORE, D
    [J]. CELL, 1986, 46 (05) : 705 - 716